Phase 3 Oesophageal Cancer Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
Esophageal CancerOesophageal CancerSquamous Cell Esophageal Carcinoma
Sun Yat-sen University422 enrolled1 locationNCT05357846
Recruiting
Phase 2Phase 3
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Gastric CancerPancreatic Ductal AdenocarcinomaOncology+3 more
KU Leuven109 enrolled3 locationsNCT06782412
Completed
Phase 3
Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies (TARGET-TP)
Liver CancerPancreatic CancerLung Cancer+4 more
Peter MacCallum Cancer Centre300 enrolled5 locationsACTRN12618000811202
Completed
Phase 3
A Randomised Phase III Double-Blind Placebo-Controlled Study of regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)
Advanced (metastatic or locally recurrent) Gastro-Oesophageal Cancer (AGOC)
The Australasian Gastro-Intestinal Trials Group (AGITG)350 enrolled32 locationsACTRN12616000420448